Monthly Archives: February 2013

Daiichi Sankyo Faces Gender Discrimination Lawsuit

Six current and former female pharmaceutical sales representatives have filed a $100-million gender discrimination lawsuit against Daiichi Sankyo in a US district court. The company employs around 3000 people in the US. According to a statement from the law firm Sanford Heisler, which is representing the case, Daiichi Sankyo pays female sales reps less than […]
Posted in Guest Blog, Legal | Tagged | Leave a comment

IOM: Curb Fake Meds through Track-and-Trace, but Forget "Counterfeits"

A new report from the Institute of Medicine (IOM) has drawn a lot of attention to the public health dangers of falsified and substandard medicines around the world. The aim is to build support for a range of activities that can limit the spread of fake medicines in the U.S. and help developing nations strengthen […]
Posted in Anti-counterfeiting, compliance, Events, FDA, Manufacturing, R&D, Regulatory, Safety, Strategy, Supply Chain | Tagged , , , , , | Leave a comment

Getting it Done in Washington

During his fifth State of the Union address, President Obama struck many familiar chords – including a line about ending certain subsidies to pharmaceutical companies – and emphasized, repeatedly, the need to get things done on the policy front. Will the sequestration drum beat goad members of the 113th Congress onto the dance floor?
Posted in healthcare, Legal, pricing, R&D, Strategy | Tagged , , , , , , , | Leave a comment

Should CEOs Use Social Media?

Yes, writes Peter Houston, but you don’t have to do it all yourself. You probably have bigger calls on your time, but have you given much thought to social media? Not in the abstract corporate communications sense, in a you-the-CEO sense? There has been a flurry of reports over the last six months about the […]
Posted in Guest Blog, social media | Tagged , , | 3 Comments

Pharma's Most Productive Innovators: The Top Ten

By Stephanie Sutton, PharmTech Europe. Consultancy firm IDEA Pharma has released what it calls a ‘Productive Innovation Index’, which ranks pharmaceutical companies based on their ability to successfully commercialize new innovations. The company has been published the index for three years and uses publicly available data to reach its conclusions. Although the index may not […]
Posted in Guest Blog | Tagged , | 2 Comments
  • Categories

  • Meta